AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases

Written By Dean A. Wetherbee

https://www.globenewswire.com/news-release/2026/05/11/3291817/0/en/agc-biologics-joins-orphan-therapeutics-accelerator-s-clinical-development-network-as-a-manufacturing-partner-to-advance-cell-and-gene-therapies-for-ultra-rare-diseases.html

Dean A. Wetherbee
Previous

ASGCT and Orphan Therapeutics Accelerator Launch CGTxchange -- A First-of-Its-Kind Marketplace to Reactivate Promising Shelved Cell and Gene Therapy Programs
Next

P4ML Becomes Founding Member of Orphan Therapeutics Accelerator (OTXL) to Support Broader Global Access to Ultra-Rare Disease Treatments